Holen Sie sich die Stockscreener-App
17.52
0.37%
0.065
Handel nachbörslich:
17.60
0.075
+0.43%
Schlusskurs vom Vortag:
$17.46
Offen:
$17.52
24-Stunden-Volumen:
28,295
Relative Volume:
0.42
Marktkapitalisierung:
$186.43M
Einnahmen:
$19.85M
Nettoeinkommen (Verlust:
$-12.75M
KGV:
-12.70
EPS:
-1.38
Netto-Cashflow:
$-21.94M
1W Leistung:
+1.59%
1M Leistung:
+8.25%
6M Leistung:
+1.39%
1J Leistung:
-1.04%
1-Tages-Spanne:
$17.34
$17.60
1-Wochen-Bereich:
$17.10
$18.23
52-Wochen-Spanne:
$12.78
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
Vergleichen Sie MDWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.52 | 186.43M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
MediWound Ltd. (NASDAQ:MDWD) Shares Sold by Renaissance Technologies LLC - Defense World
Will VALUE Add More Value To MediWound? - RTTNews
MediWound to Report First Quarter 2025 Financial Results - The Manila Times
Enzymatic Therapeutics Leader MediWound Sets Q1 2025 Earnings CallKey Updates Expected - Stock Titan
MediWound (NASDAQ:MDWD) Earns Buy Rating from Analysts at Alliance Global Partners - Defense World
(MDWD) Technical Data - news.stocktradersdaily.com
MediWound (MDWD) Gains Buy Rating with Promising Future Prospect - GuruFocus
Geode Capital Management LLC Grows Stock Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound (MDWD) to Showcase Innovative Wound Care Research at K - GuruFocus
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - GlobeNewswire
Breakthrough Wound Care Data: EscharEx Outperforms SANTYL in Latest Clinical Studies - Stock Titan
MediWound Ltd. (NASDAQ:MDWD) Stake Increased by Russell Investments Group Ltd. - Defense World
Wells Fargo & Company MN Cuts Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
What You Can Learn From MediWound Ltd.'s (NASDAQ:MDWD) P/S - simplywall.st
Those who invested in MediWound (NASDAQ:MDWD) five years ago are up 30% - Yahoo Finance
MediWound schedules annual shareholder meeting for May 15 By Investing.com - Investing.com Canada
MediWound schedules annual shareholder meeting for May 15 - Investing.com Australia
MediWound Announces 2025 Annual General Meeting and Key Agenda Items - TipRanks
Trading (MDWD) With Integrated Risk Controls - news.stocktradersdaily.com
What is HC Wainwright’s Estimate for MediWound Q1 Earnings? - The AM Reporter
HC Wainwright Has Bearish Estimate for MediWound Q1 Earnings - Defense World
HC Wainwright Reiterates Buy Rating for MediWound (NASDAQ:MDWD) - The AM Reporter
StockNews.com Upgrades MediWound (NASDAQ:MDWD) to “Sell” - Defense World
HC Wainwright Reaffirms Buy Rating for MediWound (NASDAQ:MDWD) - Defense World
HC Wainwright Comments on MediWound FY2029 Earnings - Defense World
When (MDWD) Moves Investors should Listen - news.stocktradersdaily.com
MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Lo - GuruFocus.com
MediWound Full Year 2024 Earnings: EPS Beats Expectations - simplywall.st
Loss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-Term - Yahoo
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses - Yahoo Finance
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue G - GuruFocus
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses By GuruFocus - Investing.com Canada
MediWound Reports 2024 Financials and Strategic Advances - TipRanks
MediWound Files for $125 Million Mixed Shelf -March 19, 2025 at 04:55 pm EDT - Marketscreener.com
Mediwound files for mixed shelf offering of up to $125 mln -March 19, 2025 at 04:16 pm EDT - Marketscreener.com
Earnings call transcript: MediWound Q4 2024 beats EPS expectations By Investing.com - Investing.com Australia
MediWound: Q4 Earnings Snapshot - mySA
Earnings call transcript: MediWound Q4 2024 beats EPS expectations - Investing.com India
Mediwound Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
MediWound shares rise as Q4 loss is narrower than expected By Investing.com - Investing.com South Africa
MediWound shares rise as Q4 loss is narrower than expected - Investing.com India
Mediwound earnings beat by $0.20, revenue topped estimates - Investing.com India
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Top Premarket Gainers -March 19, 2025 at 07:48 am EDT - Marketscreener.com
MediWound Reports 2024 Financial Results and Strategic Advances - TipRanks
MediWound: Q4 Earnings Snapshot -March 19, 2025 at 07:18 am EDT - Marketscreener.com
MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):